ClinicalTrials.Veeva

Menu

Prospective Use of Awake Endoscopy for Inspire Activation

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Obstructive Sleep Apnea

Treatments

Diagnostic Test: Awake endoscopy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to examine a new method of device configuration for the Inspire upper airway stimulator. First, the investigators will attempt to determine optimal configuration by quantifying changes in upper airway size with different implant configurations using awake nasal endoscopy. The configuration/voltage that results in the greatest increase in upper airway size and is tolerated by the patient will be selected. Participants will then undergo a sleep study so that increased airway size may be correlated with changes in sleep study parameters including AHI and oxygen desaturation index (ODI). Airway size and sleep study parameters using the standard device configuration (+-+)/voltage will be compared to airway size and sleep study parameters using the test, or "optimal," configuration/voltage to determine the usefulness of awake endoscopy in activation of the Inspire device.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with moderate to severe OSA who have undergone Inspire UAS implantation by the principal investigator
  • Must have symptoms of OSA prior to Inspire implantation
  • AHI between 15 and 65, where central and mixed apnea is 25% or more, and the level of collapse is in the soft palate area BMI less than 32
  • Age 18 or above

Exclusion criteria

  • Significant central sleep apnea
  • Presence of other sleep disorders
  • History of neurologic or neuromuscular disease
  • Historical or present substance abuse
  • Bleeding disorders
  • Autoimmune diseases that increase risk of nasal trauma such as Wegener's, Sarcoidosis, etc.
  • Pregnancy

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

All subjects
Other group
Description:
Awake endoscopic exam will be performed to measure airway size in the retropalatal and retroglossal upper airway regions using different Inspire implant configurations and voltages.
Treatment:
Diagnostic Test: Awake endoscopy

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems